Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Urothelial Cancer × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 57 Lung Neoplasms 45 Glioblastoma 45 Breast Neoplasms 37 Head and Neck Neoplasms 34 Prostatic Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 29 Esophageal Neoplasms 29 Brain Neoplasms 28 Lymphoma 27 Gliosarcoma 24 Rectal Neoplasms 22 Hodgkin Disease 22 Adenocarcinoma Of Esophagus 22 Pancreatic Neoplasms 20 Central Nervous System Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Non-Hodgkin 16 Glioma 16 Neoplasms 15 Lymphoma, Large B-Cell, Diffuse 15 Leukemia 15 Burkitt Lymphoma 15 Carcinoma, Squamous Cell 14 Sarcoma 13 Lymphoma, Follicular 12 Astrocytoma 12 Lymphoma, Mantle-Cell 11 Colorectal Neoplasms 11 Adenocarcinoma of Lung 11

Interventions

Gemcitabine 4 Cisplatin 4 Carboplatin 3 pembrolizumab 2 erdafitinib 2 durvalumab 2 vinflunine 1 tremelimumab 1 enfortumab vedotin 1 avelumab 1 Sunitinib 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Midazolam 1 Metformin 1 Ipilimumab 1 Docetaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02891161 2024-11-27

DUART

Big Ten Cancer Research Consortium

Phase 1/2 Terminated

26 enrolled 20 charts

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡